| PERIOD ENDING | 28-Mar-09 | 29-Mar-08 | 31-Mar-07 | | Total Revenue | 1,825,184 | 1,841,372 | 1,842,739 | | Cost of Revenue | 669,151 | 686,988 | 718,643 | | | Gross Profit | 1,156,033 | 1,154,384 | 1,124,096 | | | Operating Expenses | | Research Development | 355,392 | 358,063 | 388,101 | | Selling General and Administrative | 343,768 | 365,325 | 377,719 | | Non Recurring | 22,023 |
-
| 2,500 | | Others | 5,332 | 6,802 | 8,009 | | | | Total Operating Expenses | 726,515 |
-
| 776,329 | | | | Operating Income or Loss | 429,518 | 424,194 | 347,767 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 97,613 | 81,901 | 83,379 | | Earnings Before Interest And Taxes | 527,131 | 506,095 | 431,146 | | Interest Expense | 28,947 | 32,001 |
-
| | Income Before Tax | 498,184 | 474,094 | 431,146 | | Income Tax Expense | 122,544 | 100,047 | 80,474 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 375,640 | 374,047 | 350,672 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 375,640 | 374,047 | 350,672 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $375,640 | $374,047 | $350,672 |
|
1.48% Nasdaq 
Income Statement
